Northern Trust Corp Solid Biosciences Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.43 - $1.24 $168,734 - $486,582	-392,405 Reduced 77.57%	113,496 $70,000
Q1 2022 May 13, 2022	SELL	$0.74 - $1.79 $24,011 - $58,081	-32,448 Reduced 6.03%	505,901 $607,000
Q4 2021 Feb 08, 2022	SELL	$1.69 - $2.46 $4,128 - $6,009	-2,443 Reduced 0.45%	538,349 $942,000
Q3 2021 Nov 15, 2021	SELL	$2.38 - $3.77 $63,531 - $100,636	-26,694 Reduced 4.7%	540,792 $1.29 Million
Q2 2021 Aug 13, 2021	BUY	$3.49 - $5.51 $875,274 - $1.38 Million	250,795 Added 79.19%	567,486 $2.08 Million
Q1 2021 May 12, 2021	SELL	$5.37 - $10.72 $117,538 - $234,639	-21,888 Reduced 6.46%	316,691 $1.75 Million
Q4 2020 Feb 11, 2021	BUY	$3.08 - $7.79 $173,933 - $439,916	56,472 Added 20.02%	338,579 $2.57 Million
Q3 2020 Nov 16, 2020	BUY	$2.02 - $3.08 $2,498 - $3,809	1,237 Added 0.44%	282,107 $573,000
Q2 2020 Aug 14, 2020	BUY	$2.1 - $3.42 $93,233 - $151,837	44,397 Added 18.77%	280,870 $822,000
Q1 2020 May 14, 2020	BUY	$2.31 - $4.43 $11,898 - $22,818	5,151 Added 2.23%	236,473 $566,000
Q4 2019 Feb 14, 2020	SELL	$2.82 - $12.9 $32,026 - $146,505	-11,357 Reduced 4.68%	231,322 $1.03 Million
Q3 2019 Nov 13, 2019	BUY	$4.33 - $11.64 $312,496 - $840,058	72,170 Added 42.33%	242,679 $2.51 Million
Q2 2019 Aug 13, 2019	BUY	$4.6 - $10.13 $24,527 - $54,013	5,332 Added 3.23%	170,509 $981,000
Q1 2019 May 13, 2019	SELL	$7.19 - $32.37 $39,365 - $177,225	-5,475 Reduced 3.21%	165,177 $1.52 Million
Q4 2018 Feb 12, 2019	BUY	$21.32 - $46.34 $81,101 - $176,277	3,804 Added 2.28%	170,652 $4.57 Million
Q3 2018 Nov 14, 2018	BUY	$36.35 - $51.7 $2.02 Million - $2.88 Million	55,633 Added 50.02%	166,848 $7.87 Million
Q2 2018 Sep 18, 2018	BUY	$7.33 - $43.15 $100,340 - $590,680	13,689 Added 14.04%	111,215 $3.96 Million
Q2 2018 Aug 14, 2018	BUY	$7.33 - $43.15 $42,169 - $248,241	5,753 Added 6.27%	97,526 $3.48 Million
Q1 2018 May 09, 2018	BUY	$7.19 - $33.17 $659,847 - $3.04 Million	91,773 New	91,773 $689,000

Others Institutions Holding SLDB

# of Institutions

Shares Held

Call Options Held

Put Options Held

View Full List

About Solid Biosciences Inc.

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $30.6M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

More about SLDB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account